Annual CFO
$10.35 B
+$537.00 M+5.48%
31 December 2023
Summary:
AstraZeneca annual cash flow from operations is currently $10.35 billion, with the most recent change of +$537.00 million (+5.48%) on 31 December 2023. During the last 3 years, it has risen by +$5.55 billion (+115.57%). AZN annual CFO is now -11.87% below its all-time high of $11.74 billion, reached on 31 December 2009.AZN Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
$3.38 B
+$298.00 M+9.66%
30 September 2024
Summary:
AstraZeneca quarterly cash flow from operations is currently $3.38 billion, with the most recent change of +$298.00 million (+9.66%) on 30 September 2024. Over the past year, it has increased by +$269.00 million (+8.64%). AZN quarterly CFO is now -17.12% below its all-time high of $4.08 billion, reached on 31 December 2009.AZN Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
$11.33 B
+$269.00 M+2.43%
30 September 2024
Summary:
AstraZeneca TTM cash flow from operations is currently $11.33 billion, with the most recent change of +$269.00 million (+2.43%) on 30 September 2024. Over the past year, it has increased by +$971.00 million (+9.37%). AZN TTM CFO is now -3.45% below its all-time high of $11.74 billion, reached on 31 December 2009.AZN TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AZN Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +5.5% | +8.6% | +9.4% |
| 3 y3 years | +115.6% | +96.8% | +78.7% |
| 5 y5 years | +295.1% | +206.7% | +196.9% |
AZN Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +115.6% | at high | +171.1% | at high | +90.1% |
| 5 y | 5 years | at high | +295.1% | at high | +2333.8% | at high | +281.7% |
| alltime | all time | -11.9% | +4915.3% | -17.1% | +442.8% | -3.5% | +2421.9% |
AstraZeneca Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $3.38 B(+9.7%) | $11.33 B(+2.4%) |
| June 2024 | - | $3.08 B(+24.1%) | $11.06 B(+14.1%) |
| Mar 2024 | - | $2.49 B(+4.5%) | $9.70 B(-6.3%) |
| Dec 2023 | $10.35 B(+5.5%) | $2.38 B(-23.6%) | $10.35 B(-0.2%) |
| Sept 2023 | - | $3.11 B(+81.3%) | $10.36 B(+1.8%) |
| June 2023 | - | $1.72 B(-45.2%) | $10.18 B(+4.8%) |
| Mar 2023 | - | $3.13 B(+30.7%) | $9.71 B(-1.0%) |
| Dec 2022 | $9.81 B(+64.5%) | $2.40 B(-18.2%) | $9.81 B(+11.1%) |
| Sept 2022 | - | $2.93 B(+134.8%) | $8.83 B(+15.9%) |
| June 2022 | - | $1.25 B(-61.4%) | $7.62 B(+4.9%) |
| Mar 2022 | - | $3.23 B(+127.9%) | $7.26 B(+21.8%) |
| Dec 2021 | $5.96 B(+24.3%) | $1.42 B(-17.5%) | $5.96 B(-6.0%) |
| Sept 2021 | - | $1.72 B(+92.7%) | $6.34 B(-1.6%) |
| June 2021 | - | $892.00 M(-53.9%) | $6.45 B(-2.2%) |
| Mar 2021 | - | $1.93 B(+7.6%) | $6.59 B(+37.4%) |
| Dec 2020 | $4.80 B(+61.6%) | $1.80 B(-1.3%) | $4.80 B(+9.7%) |
| Sept 2020 | - | $1.82 B(+75.2%) | $4.38 B(+19.7%) |
| June 2020 | - | $1.04 B(+648.2%) | $3.66 B(+4.6%) |
| Mar 2020 | - | $139.00 M(-89.9%) | $3.50 B(+17.7%) |
| Dec 2019 | $2.97 B(+13.4%) | $1.38 B(+24.7%) | $2.97 B(-22.2%) |
| Sept 2019 | - | $1.10 B(+25.6%) | $3.82 B(+19.9%) |
| June 2019 | - | $878.00 M(-326.9%) | $3.18 B(+34.3%) |
| Mar 2019 | - | -$387.00 M(-117.4%) | $2.37 B(-9.4%) |
| Dec 2018 | $2.62 B(-26.8%) | $2.22 B(+374.2%) | $2.62 B(+88.2%) |
| Sept 2018 | - | $469.00 M(+621.5%) | $1.39 B(-56.1%) |
| June 2018 | - | $65.00 M(-146.4%) | $3.17 B(-5.5%) |
| Mar 2018 | - | -$140.00 M(-114.0%) | $3.35 B(-6.4%) |
| Dec 2017 | $3.58 B(-13.7%) | $997.00 M(-55.6%) | $3.58 B(-21.2%) |
| Sept 2017 | - | $2.24 B(+797.2%) | $4.54 B(+46.1%) |
| June 2017 | - | $250.00 M(+184.1%) | $3.11 B(+2.3%) |
| Mar 2017 | - | $88.00 M(-95.5%) | $3.04 B(-26.7%) |
| Dec 2016 | $4.14 B(+24.7%) | $1.96 B(+141.7%) | $4.14 B(+50.4%) |
| Sept 2016 | - | $811.00 M(+348.1%) | $2.76 B(-25.3%) |
| June 2016 | - | $181.00 M(-84.8%) | $3.69 B(-19.6%) |
| Mar 2016 | - | $1.19 B(+108.9%) | $4.59 B(+38.1%) |
| Dec 2015 | $3.32 B(-52.9%) | $571.00 M(-67.3%) | $3.32 B(-27.7%) |
| Sept 2015 | - | $1.75 B(+61.6%) | $4.59 B(-4.3%) |
| June 2015 | - | $1.08 B(-1600.0%) | $4.80 B(-17.2%) |
| Mar 2015 | - | -$72.00 M(-103.9%) | $5.80 B(-17.8%) |
| Dec 2014 | $7.06 B(-4.6%) | $1.84 B(-5.5%) | $7.06 B(-8.3%) |
| Sept 2014 | - | $1.95 B(-6.2%) | $7.69 B(+12.1%) |
| June 2014 | - | $2.08 B(+75.1%) | $6.86 B(+7.4%) |
| Mar 2014 | - | $1.19 B(-52.1%) | $6.39 B(-13.7%) |
| Dec 2013 | $7.40 B(+6.5%) | $2.48 B(+121.6%) | $7.40 B(-4.8%) |
| Sept 2013 | - | $1.12 B(-30.4%) | $7.77 B(-2.4%) |
| June 2013 | - | $1.61 B(-26.9%) | $7.96 B(+4.7%) |
| Mar 2013 | - | $2.20 B(-22.8%) | $7.61 B(+9.5%) |
| Dec 2012 | $6.95 B(-11.2%) | $2.85 B(+117.6%) | $6.95 B(-3.1%) |
| Sept 2012 | - | $1.31 B(+4.6%) | $7.17 B(-7.9%) |
| June 2012 | - | $1.25 B(-18.8%) | $7.78 B(+4.2%) |
| Mar 2012 | - | $1.54 B(-49.8%) | $7.47 B(-4.5%) |
| Dec 2011 | $7.82 B | $3.07 B(+59.6%) | $7.82 B(-5.9%) |
| Sept 2011 | - | $1.92 B(+104.8%) | $8.31 B(-4.9%) |
| June 2011 | - | $939.00 M(-50.3%) | $8.74 B(-19.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2011 | - | $1.89 B(-46.9%) | $10.83 B(+1.4%) |
| Dec 2010 | $10.68 B(-9.0%) | $3.56 B(+51.3%) | $10.68 B(-4.7%) |
| Sept 2010 | - | $2.35 B(-22.3%) | $11.20 B(+0.3%) |
| June 2010 | - | $3.03 B(+74.1%) | $11.17 B(-0.7%) |
| Mar 2010 | - | $1.74 B(-57.4%) | $11.25 B(-4.2%) |
| Dec 2009 | $11.74 B(+34.3%) | $4.08 B(+75.7%) | $11.74 B(+12.4%) |
| Sept 2009 | - | $2.32 B(-25.2%) | $10.45 B(+6.8%) |
| June 2009 | - | $3.11 B(+39.5%) | $9.78 B(+14.1%) |
| Mar 2009 | - | $2.23 B(-20.2%) | $8.58 B(-1.9%) |
| Dec 2008 | $8.74 B(+16.4%) | $2.79 B(+68.2%) | $8.74 B(-2.3%) |
| Sept 2008 | - | $1.66 B(-12.7%) | $8.95 B(+3.8%) |
| June 2008 | - | $1.90 B(-20.5%) | $8.62 B(+11.7%) |
| Mar 2008 | - | $2.39 B(-20.2%) | $7.71 B(+2.7%) |
| Dec 2007 | $7.51 B(-2.4%) | $3.00 B(+125.8%) | $7.51 B(+12.6%) |
| Sept 2007 | - | $1.33 B(+33.2%) | $6.67 B(-10.5%) |
| June 2007 | - | $997.00 M(-54.4%) | $7.46 B(-10.9%) |
| Mar 2007 | - | $2.19 B(+1.3%) | $8.37 B(+8.8%) |
| Dec 2006 | $7.69 B(+14.1%) | $2.16 B(+2.3%) | $7.69 B(+3.1%) |
| Sept 2006 | - | $2.11 B(+10.6%) | $7.46 B(+6.4%) |
| June 2006 | - | $1.91 B(+26.3%) | $7.01 B(+3.9%) |
| Mar 2006 | - | $1.51 B(-21.6%) | $6.75 B(+0.0%) |
| Dec 2005 | $6.74 B(+40.0%) | $1.93 B(+16.2%) | $6.74 B(-1.3%) |
| Sept 2005 | - | $1.66 B(+0.9%) | $6.83 B(+8.7%) |
| June 2005 | - | $1.65 B(+9.0%) | $6.29 B(+24.7%) |
| Mar 2005 | - | $1.51 B(-25.2%) | $5.04 B(+4.7%) |
| Dec 2004 | $4.82 B(+43.0%) | $2.02 B(+80.8%) | $4.82 B(+59.4%) |
| Sept 2004 | - | $1.12 B(+178.3%) | $3.02 B(+2.3%) |
| June 2004 | - | $401.00 M(-68.7%) | $2.95 B(-15.3%) |
| Mar 2004 | - | $1.28 B(+474.9%) | $3.49 B(+3.5%) |
| Dec 2003 | $3.37 B(-30.3%) | $223.00 M(-78.7%) | $3.37 B(-14.2%) |
| Sept 2003 | - | $1.05 B(+12.1%) | $3.93 B(-7.6%) |
| June 2003 | - | $933.92 M(-19.8%) | $4.25 B(+2.3%) |
| Mar 2003 | - | $1.16 B(+49.0%) | $4.15 B(-14.1%) |
| Dec 2002 | $4.83 B(+54.6%) | $780.92 M(-43.0%) | $4.83 B(+3.1%) |
| Sept 2002 | - | $1.37 B(+63.7%) | $4.69 B(+11.3%) |
| June 2002 | - | $837.00 M(-54.6%) | $4.21 B(+13.0%) |
| Mar 2002 | - | $1.84 B(+189.6%) | $3.73 B(+19.3%) |
| Dec 2001 | $3.13 B(+33.8%) | $637.00 M(-28.7%) | $3.13 B(+108.1%) |
| Sept 2001 | - | $894.00 M(+153.9%) | $1.50 B(-42.6%) |
| June 2001 | - | $352.04 M(-71.7%) | $2.62 B(-16.3%) |
| Mar 2001 | - | $1.24 B(-225.9%) | $3.13 B(+34.0%) |
| Dec 2000 | $2.34 B(+9.9%) | -$986.91 M(-149.1%) | $2.34 B(-29.7%) |
| Sept 2000 | - | $2.01 B(+133.1%) | $3.32 B(+153.2%) |
| June 2000 | - | $862.75 M(+92.0%) | $1.31 B(+192.0%) |
| Mar 2000 | - | $449.42 M | $449.42 M |
| Dec 1999 | $2.13 B(-37.9%) | - | - |
| Dec 1998 | $3.42 B(+358.0%) | - | - |
| Dec 1997 | $747.21 M(-5.1%) | - | - |
| Dec 1996 | $787.75 M(+34.5%) | - | - |
| Dec 1995 | $585.64 M(-6.4%) | - | - |
| Dec 1994 | $625.36 M(-11.4%) | - | - |
| Dec 1993 | $705.58 M(+242.1%) | - | - |
| Dec 1992 | $206.27 M(-59.2%) | - | - |
| Dec 1991 | $505.22 M(-37.3%) | - | - |
| Dec 1990 | $806.30 M | - | - |
FAQ
- What is AstraZeneca annual cash flow from operations?
- What is the all time high annual CFO for AstraZeneca?
- What is AstraZeneca annual CFO year-on-year change?
- What is AstraZeneca quarterly cash flow from operations?
- What is the all time high quarterly CFO for AstraZeneca?
- What is AstraZeneca quarterly CFO year-on-year change?
- What is AstraZeneca TTM cash flow from operations?
- What is the all time high TTM CFO for AstraZeneca?
- What is AstraZeneca TTM CFO year-on-year change?
What is AstraZeneca annual cash flow from operations?
The current annual CFO of AZN is $10.35 B
What is the all time high annual CFO for AstraZeneca?
AstraZeneca all-time high annual cash flow from operations is $11.74 B
What is AstraZeneca annual CFO year-on-year change?
Over the past year, AZN annual cash flow from operations has changed by +$537.00 M (+5.48%)
What is AstraZeneca quarterly cash flow from operations?
The current quarterly CFO of AZN is $3.38 B
What is the all time high quarterly CFO for AstraZeneca?
AstraZeneca all-time high quarterly cash flow from operations is $4.08 B
What is AstraZeneca quarterly CFO year-on-year change?
Over the past year, AZN quarterly cash flow from operations has changed by +$269.00 M (+8.64%)
What is AstraZeneca TTM cash flow from operations?
The current TTM CFO of AZN is $11.33 B
What is the all time high TTM CFO for AstraZeneca?
AstraZeneca all-time high TTM cash flow from operations is $11.74 B
What is AstraZeneca TTM CFO year-on-year change?
Over the past year, AZN TTM cash flow from operations has changed by +$971.00 M (+9.37%)